Bioscience Americas Selects JCF Capital Advisors as Strategic Growth Partner

Share Article

Bioscience Americas, a world leader in developing adult stem cell treatment centers, is well positioned for rapid international growth.

Bioscience Americas, LLC, a leading developer of adult stem cell treatment centers, announced today that they have retained San Diego, California based JCF Capital Advisors, LLC (JCF), a boutique capital advisory firm, to advise in the implementation of its international growth plan. JCF will also assist in strategically advising to raise or place Bioscience Americas equity capital financing with select family office and other institutional accredited investors.

Bioscience Americas is the international development partner of the Global Institute of Stem Cell Therapy and Research. Headquartered at the University of California Medical Center in San Diego, the Global Institute is a consortium of top autologous stem cell scientists from around the world. The Global Institute and Bioscience Americas have been the beneficiary of more than $400 million in research capital over the last fifteen years. Working with Bioscience Americas, the Global Institute has successfully introduced proven adult stem cell therapies from the lab to the marketplace.

JCF Capital Advisors provides professional capital advisory, management consulting, merger and acquisition, and sell-side services to early stage and mid-market companies.

In commenting on the new relationship, Bioscience Americas CEO Eric Stoffers said that JCF was selected to assist the biotechnology venture because of JCF’s proven ability to structure complex international transactions as well as source developmental capital. “JCF represents the perfect strategic partner for Bioscience Americas. As we grow, JCF is scaled to work with us as we enhance our international presence through its private equity channels and M&A expertise”, Mr. Stoffers said.

Justin Floyd, JCF’s Managing Director, noted as well that Bioscience Americas and its world-class science capabilities represent a paradigm shift in how patients are treated. “Autologous stem cell science represents the future of medicine. We are pleased to be able to help position Bioscience Americas for tremendous growth now and in the years ahead”, Mr. Floyd added.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bill Deegan
@WeAreBioAm
since: 08/2015
Follow >
Bioscience Americas
since: 07/2015
Like >
Visit website